BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29902849)

  • 1. [Application of Mohs microsurgery in nasal basal cell carcinoma].
    Ma WY; Liu W; Li XZ; Ye P; Zhang LQ; Cai XL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jun; 53(6):440-443. PubMed ID: 29902849
    [No Abstract]   [Full Text] [Related]  

  • 2. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
    van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
    Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
    Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
    Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mohs' method of micrographic surgery as treatment for recurrent basal cell carcinoma].
    van Baardwijk AA; Verhaegh ME; Krekels GA; Vermeulen AH; Neumann HA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(11):524-9. PubMed ID: 9190509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
    Sin CW; Barua A; Cook A
    Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial basal cell carcinomas of the head and neck.
    Mina MA; Picariello A; Fewkes JL
    Dermatol Surg; 2013 Jul; 39(7):1003-8. PubMed ID: 23465089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of the influence of patient-, tumor-, and management-related factors on the outcome of surgical therapy for facial basal-cell carcinoma.
    Mueller CK; Nicolaus K; Thorwarth M; Schultze-Mosgau S
    Oral Maxillofac Surg; 2010 Sep; 14(3):163-8. PubMed ID: 20349095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the micrographic surgery in the management of basal cell carcinoma: experience in the Department of Dermatology, at the Hassan II University Hospital, Fes, Morocco].
    Gallouj S; Aqil N; Harmouch T; Mernissi FZ
    Pan Afr Med J; 2019; 33():245. PubMed ID: 31692779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mohs micrographic surgery for periocular skin tumours in Ireland.
    Treacy MP; Wynne NC; Gale JL; Duignan E; Moran B; Flynn AM; Ormond P; Barry R; Khan R; Moriarty P; Cassidy L
    Ir J Med Sci; 2016 Nov; 185(4):779-783. PubMed ID: 26159430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma].
    Blázquez-Sánchez N; de Troya-Martín M; Frieyro-Elicegui M; Fúnez-Liébana R; Martín-Márquez L; Rivas-Ruiz F
    Actas Dermosifiliogr; 2010 Sep; 101(7):622-8. PubMed ID: 20858388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
    van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
    Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial reconstruction following Mohs micrographic surgery: a report of 622 cases.
    Grosfeld EC; Smit JM; Krekels GA; van Rappard JH; Hoogbergen MM
    J Cutan Med Surg; 2014; 18(4):265-70. PubMed ID: 25008443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predictive of complex Mohs surgery cases.
    Sahai S; Walling HW
    J Dermatolog Treat; 2012 Dec; 23(6):421-7. PubMed ID: 21787205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancer: a review with consideration of treatment options including Mohs micrographic surgery.
    Lambert DR; Siegle RJ
    Ohio Med; 1990 Oct; 86(10):745-7. PubMed ID: 2234766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mohs surgery in basal cell carcinoma on the face].
    Roscher I; Brevig T; Mørk G; Helsing P; Gjersvik P
    Tidsskr Nor Laegeforen; 2011 Dec; 131(24):2475-9. PubMed ID: 22170133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and Argument for Subunit Mohs Excision in Nasal Reconstruction.
    Jergensen ZR; Pezeshk RA; Thornton JF
    J Cutan Med Surg; 2016 Jul; 20(4):343-5. PubMed ID: 26834120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.